Introduction of Chlamydia trachomatis screening for young women in Germany;Einführung des Chlamydia-trachomatis-screenings für junge frauen in Deutschland

JDDG - Journal of the German Society of Dermatology

Volumn 6, Issue 12, 2008, Pages 1032-1037

  Mund, Monika ^a,d   Sander, Gabriele ^a   Potthoff, Peter ^a   Schicht, Helga ^b   Matthias, Katja ^c  

^a Kassenarztliche Bundesvereinigung   (Germany)

^b Medizinischer Dienst der Krankenkassen   (Germany)

^c AOK Bundesverband   (Germany)

^d Dezernat Versorgungsqualität und Sicherstellung ^*  (Germany)

Author keywords

Chlamydia trachomatis; Mass screening; Nucleic acid amplification techniques (NAAT); Pelvic inflammatory disease (PID); Sexually transmitted diseases (STD); Urogenital diseases

Indexed keywords

ABORTION; BACTERIAL INFECTION; CHLAMYDIA TRACHOMATIS; DECISION MAKING; ECTOPIC PREGNANCY; FEMALE INFERTILITY; GENITAL TRACT INFECTION; GERMANY; HEALTH; HUMAN; MEDICAL CARE; MEDICAL INFORMATION; MEDICAL SOCIETY; PREVALENCE; REVIEW; SCREENING;

ADOLESCENT; ADULT; CHILD; CHLAMYDIA TRACHOMATIS; CHLAMYDIACEAE INFECTIONS; FEMALE; GERMANY; HUMANS; MASS SCREENING; WOMEN'S HEALTH; YOUNG ADULT;

EID: 57449113640     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2008.06743.x     Document Type: Review

References (31)

1. World Health Organisation. Global prevalence and incidence of selected curable sexually transmitted infections: Chlamydia estimates 1999. WHO 2003. http://www.who.int/docstore/hiv/GRSTI/003.htm
2. Westrom LV. Sexually transmitted diseases and infertility. Sex Transm Dis. 1994 21 (2 Suppl S32 37.
3. Gille G, Klapp C, Diedrich K, Schäfer A, Moter A, Griesinger G, Kirschner R. Chlamydien - eine heim-liche Epidemie unter Jugendlichen. Prävalenzbeobachtung bei jungen Mädchen in Berlin. DÄ 2005 102 (28-29 A 2021.
4. Koch J, Kirschner R, Schäfer A. Bestimmung der Prävalenz genitaler HPV - und Chlamydia trachomatis-Infektionen in einem repräsentativen Querschnitt der weiblichen Normalbevölkerung in Berlin. Epid Bull 1997 18 : 121 122.
5. Bremer V. Gonorrhö und genitale Chlamydiose in Deutschland nach Daten des STD-Sentinels des RKI. Epid Bull 2004 39 : 331 335.
6. Nelson HD, Saha S, Helfand M. Screening for Chlamydial Infection. Systematic Evidence Review Number 3. AHRQ 2001 Publication No.01-S003.
7. L'Agence Nationale dAccreditation d'Evaluation en Santé (ANAES). Evaluation du dépistage des infections urogenitales basées à Chlamydia trachomatis en France. ANAES 2003.
8. Canadian Task Force on the Periodic Health Examination, 1996: Periodic health examination, 1996 update: 2. Screening for chlamydial infections.
9. Centers for Disease Control and Prevention (CDC). Screening Tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae Infection. CDC 2002.
10. Centers for Disease Control and Prevention (CDC). Recommendations for the Prevention and Management of Chlamydia trachomatis Infections. CDC 1993.
11. Health Council for the Netherlands. Screening for Chlamydia. Health Council for the Netherlands 2004.
12. De Carvalho Gomes H, Velasco-Garrido M, Busse R. Screening auf urogenitale Chlamydia trachomatis-Infektionen. DAHTA@DIMDI 2005.
13. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996 334 (21 1362 1366.
14. Kamwendo F, Forslin L, Bodin L, Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease: A 25-year study from an urban area of central Sweden. Sex Transm Dis 1991 23 (5 384 391.
15. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. UK National Screening Committee (NSC). http://www.nsc.nhs.uk 2007.
16. Wilson JMG, Jungner G. Principles and practice of screening for disease. Public Health Paper Number 34. Geneva : WHO, 1968.
17. Bekanntmachung vom 23.04.01 über die Zulassung und Registrierung von Arzneimitteln, Verminderung des Risikos von HIV-Infektionen durch zelluläre Blutprodukte und gefrorenes Frischplasma. Paul-Ehrlich-Institut. Bundesanzeiger 16.05.2001, Nr.90 S.9506.
18. Bang D, Angelso L, Schirakow B, Westh H. Comparison of the Becton Dickinson strand displacement amplification and Cobas Amplicor Roche PCR for the detection of Chlamydia trachomatis: pooling versus individual tests. Clin Microbiol.Infect. 2003 9 (10 1020 1023.
19. Clark AM, Steece R, Crouse K, Campbell J, Zanto S, Kartchner D, Mottice S, Pettit D. Multisite pooling study using ligase chain reaction in screening for genital Chlamydia trachomatis infections. Sex Transm Dis 2001 28 (10 565 568.
20. Currie MJ, McNiven M, Yee T, Schiemer U, Bowden FJ. Pooling of clinical specimens prior to testing for Chlamydia trachomatis by PCR is accurate and cost saving. J Clin Microbiol 2004 42 (10 4866 4867.
21. Diamant J, Benis R, Schachter J, Moncada J, Pang F, Jha HC, Bhatta RC, Porco T, Lietman T. Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic Epidemiol 2001 8 (2-3 109 117.
22. Gomes JP, Ferreira MA, De Sa AB, Catry MA. Pooling urine samples for PCR screening of C. trachomatis urogenital infection in women. Sex Transm Infect. 2001 77 (1 76 77.
23. Gomes JP, Viegas S, Paulino A, Catry MA. Sensitivity evaluation of the Gen-Probe AMP-CT assay by pooling urine samples for the screening of Chlamydia trachomatis urogenital infection. Int J STD AIDS 2002 13 (8 540 542.
24. Kacena KA, Quinn SB, Howell MR, Madico GE, Quinn TC, Gaydos CA. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol 1998 36 (2 481 485.
25. Kapala J, Copes D, Sproston A, Patel J, Jang D, Petrich A, Mahony J, Biers K, Chernesky M. Pooling cervical swabs and testing by ligase chain reaction are accurate and cost-saving strategies for diagnosis of Chlamydia trachomatis. J Clin Microbiol 2000 38 (7 2480 2483.
26. Krepel J, Patel J, Sproston A, Hopkins F, Jang D, Mahony J, Chernesky M. The impact on accuracy and cost of ligase chain reaction testing by pooling urine specimens for the diagnosis of Chlamydia trachomatis infections. Sex Transm Dis 1999 26 (9 504 507.
27. Lindan C, Mathur M, Kumta S, Jerajani H, Gogate A, Schachter J, Moncada J. Utility of pooled urine specimens for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in men attending public sexually transmitted infection clinics in Mumbai, India, by PCR. J Clin Microbiol 2005 43 (4 1674 1677.
28. Lisby G, Scheibel J, Abrahamsson LO, Christensen ES, Paloheimo S. Detection of Chlamydia trachomatis in individual and pooled endocervical and urethral scrapes by a commercially available polymerase chain reaction. APMIS 1994 102 (10 797 800.
29. Morre SA, Meijer CJ, Munk C, Kruger-Kjaer S, Winther JF, Jorgensens HO, van den Brule AJ. Pooling of urine specimens for detection of asymptomatic Chlamydia trachomatis infections by PCR in a low-prevalence population: cost-saving strategy for epidemiological studies and screening programs. J Clin Microbiol 2000 38 (4 1679 1680.
30. Morre SA, van Dijk R, Meijer CJ, van den Brule AJ, Kjaer SK, Munk C. Pooling cervical swabs for detection of Chlamydia trachomatis by PCR: sensitivity, dilution, inhibition, and cost-saving aspects. J Clin Microbiol 2001 39 (6 2375 2376.
31. Peeling RW, Toye B, Jessamine P, Gemmill I. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect. 1998 74 (1 66 70.